Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes
Abstract Leucine-rich repeat kinase 2 (LRRK2) is a large multidomain protein implicated in the pathogenesis of both familial and sporadic Parkinson’s disease (PD), and currently one of the most promising therapeutic targets for drug design in Parkinson’s disease. In contrast, LRRK1, the closest homo...
Guardado en:
Autores principales: | Kushal Sejwal, Mohamed Chami, Hervé Rémigy, Renée Vancraenenbroeck, William Sibran, Rosmarie Sütterlin, Paul Baumgartner, Robert McLeod, Marie-Christine Chartier-Harlin, Veerle Baekelandt, Henning Stahlberg, Jean-Marc Taymans |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b9e5473e709a4a3ca47905077e0c271d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.
por: Jean-Marc Taymans, et al.
Publicado: (2011) -
Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10
por: Xiang Wang, et al.
Publicado: (2021) -
LRRK2 levels in immune cells are increased in Parkinson’s disease
por: D. A. Cook, et al.
Publicado: (2017) -
LRRK2 regulates retrograde synaptic compensation at the Drosophila neuromuscular junction
por: Jay Penney, et al.
Publicado: (2016) -
Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels
por: Rubén Fernández-Santiago, et al.
Publicado: (2021)